Janssen Biotech, Inc.

Janssen Biotech, Inc. is a global pharmaceutical and biotechnology company that develops, manufactures, and markets innovative medications and treatments for a wide range of medical conditions.

Their mission is to transform patient care through the development of cutting-edge products that improve human health and well-being.

Janssen Biotech is a subsidiary of Johnson & Johnson, one of the largest and most respected healthcare companies in the world.

The company is headquartered in Horsham, Pennsylvania, and has additional facilities in California, Massachusetts, and the Netherlands.

Janssen Biotech has a focus on five key therapeutic areas: oncology, immunology, neuroscience, infectious diseases, and cardiovascular and metabolic diseases.

Some of the company’s most notable products include the cancer drugs Imbruvica and Darzalex, as well as the immunology drug Stelara.

In addition to its core business of developing and manufacturing pharmaceutical products, Janssen Biotech is also committed to social responsibility and sustainability.

The company has implemented initiatives to promote environmental sustainability, and has also established programs to support local communities and improve access to healthcare services.

Leave a Reply

Your email address will not be published. Required fields are marked *